Europe
Medtronic plc, the global leader in medical technology, announced it will participate in the Barclays Global Healthcare Conference 2019 on Tuesday, March 12, 2019, in Miami, Florida.
Medtronic plc, the global leader in medical technology, announced it will participate in the 39th Annual Cowen and Company Healthcare Conference on Monday, March 11, 2019, in Boston, Massachusetts.
Lonza announced the completion of the divestment of its former Water Care business and operations to Platinum Equity for USD 630 million.
Until recently, they were considered to be the three pillars of cancer treatment. Recent years have added a fourth pillar to surgery, radiation and chemotherapy—immuno-oncology.
NOXXON Pharma N.V. announced that the company will present the latest safety, survival and more mature clinical data in patients treated with the CXCL12 inhibitor NOX-A12 in combination with Merck & Co./MSD’s PD-1 inhibitor Keytruda® in metastatic, microsatellite stable pancreatic and colorectal cancer patients.
Evotec AG announced that another promising small molecule from its multi-target alliance with Bayer has advanced into Phase II clinical development for the treatment of persistent chronic cough.
Grafton(TM) DBM Product Will Provide More Options for Spine and Orthopedic Surgeons in Japan
IDMC recommends study can enrol children and infants aged from 21 days to 4 years
Recipharm, the contract development and manufacturing organisation, has achieved the new ISO 45001 certification at its Wasserburg facility in Germany.
Medigene AG announced that researchers of the Company will present a poster at the 2019 American Association for Cancer Research Annual Meeting.
PRESS RELEASES